SCHEMBL928256

SCHEMBL928256

C[CH]C(C)=S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7364620 0.70
SCHEMBL8058026 0.70
SCHEMBL11023144 0.70
SCHEMBL1193463 0.67
SCHEMBL3652037 0.67
SCHEMBL1988625 0.67
SCHEMBL3021840 0.67
SCHEMBL31115 0.65
SCHEMBL9020849 0.64
SCHEMBL5084453 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 100 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113087743-B Tetrahydrocannabinol derivative, preparation method thereof and medical application thereof 成都百裕制药股份有限公司 2023-04-28 CN disclosed
CN-113087741-B Cannabidiol derivative, preparation method and medical application thereof 成都百裕制药股份有限公司 2023-04-28 CN disclosed
US-20230042328-A1 IONIC LIQUID FOR STABILIZING VISCOSITY OF SILICATE-BASED COATINGS BASF SE (DE) 2023-02-09 US disclosed
US-20230002425-A1 CANNABIDIOL DERIVATIVES, PREPARATION METHOD THEREOF AND USE THEREOF CHENGDU BAIYU PHARMACEUTICAL CO., LTD. (CN) 2023-01-05 US disclosed
WO-2021139740-A1 TETRAHYDROCANNABINOL DERIVATIVE, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF 成都百裕制药股份有限公司 2021-07-15 WO disclosed
WO-2021139739-A1 CANNABIDIOL DERIVATIVE, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF 成都百裕制药股份有限公司 2021-07-15 WO disclosed
WO-2021139741-A1 CANNABIDIOL DERIVATIVE, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF 成都百裕制药股份有限公司 2021-07-15 WO disclosed
CN-113087741-A Cannabidiol derivative, preparation method and medical application thereof 成都百裕制药股份有限公司 2021-07-09 CN disclosed
CN-113087743-A Tetrahydrocannabinol derivatives, preparation method and medical application thereof 成都百裕制药股份有限公司 2021-07-09 CN disclosed
CN-113087599-A Cannabidiol derivative, preparation method and medical application thereof 成都百裕制药股份有限公司 2021-07-09 CN disclosed
WO-2003068234-A1 NICOTINAMIDE DERIVATIVES AND A TIOTROPIUM SALT IN COMBINATION FOR THE TREATMENT OF E.G. INFLAMMATORY, ALLERGIC AND RESPIRATORY DISEASES PFIZER LIMITED (GB) 2003-08-21 WO disclosed
WO-2003068233-A1 NICOTINAMIDE DERIVATIVES AND A TIOTROPIUM SALT IN COMBINATION FOR THE TREATMENT OF E.G. INFLAMMATORY, ALLERGIC AND RESPIRATORY DISEASES PFIZER LIMITED (GB) 2003-08-21 WO disclosed
EP-0883599-B1 AMINOTETRALIN DERIVATIVES AND COMPOSITIONS AND METHOD OF USE THEREOF ASTRAZENECA AB (SE) 2002-06-05 EP disclosed
US-6204222-B1 SUITABLE AS HERBICIDES AND FOR DESICCATION/DEFOLIATION OF PLANTS BASF AKTIENGESELLSCHAFT (DE) 2001-03-20 US disclosed
EP-0883599-A1 AMINOTETRALIN DERIVATIVES AND COMPOSITIONS AND METHOD OF USE THEREOF ZENECA LIMITED (GB) 1998-12-16 EP disclosed
US-5817603-A HERBICIDES BASF AKTIENGESELLSCHAFT (DE) 1998-10-06 US disclosed
US-5807897-A MUSCULAR DISORDERS ZENECA LIMITED (GB) 1998-09-15 US disclosed
WO-1997031887-A1 AMINOTETRALIN DERIVATIVES AND COMPOSITIONS AND METHOD OF USE THEREOF ZENECA LIMITED (GB) 1997-09-04 WO disclosed
EP-0628026-A1 CYANO-OXIME ETHERS, PROCESS FOR PRODUCING THEM, AGENTS CONTAINING THEM AND THEIR USE. BASF AG (DE) 1994-12-14 EP disclosed
WO-1993016985-A1 CYANO-OXIME ETHERS, PROCESS FOR PRODUCING THEM, AGENTS CONTAINING THEM AND THEIR USE BASF AKTIENGESELLSCHAFT (DE) 1993-09-02 WO disclosed